Dr. Debra Marshall is the Chief Medical Officer at ARCA Biopharma. Dr. Marshall joined ARCA in 2016 and has spent more than 20 years dedicated to cardiovascular drug development. Through her career in pharma and biotech she advanced to roles of senior leadership that involved development and approval of medicines for Heart failure, Hypertension, Acute Coronary Syndromes and Dyslipidemias. Prior to joining ARCA, she served as an Executive Medical Director in the Cardiovascular Therapeutic Area at Amgen, Senior Medical Director in Cardio-Metabolism at Genentech, Global Senior Medical Director for the CV/Acute Care team at Lilly and Associate Medical Director for CV Medical Affairs at Novartis Pharmaceutical Corporation.
Dr. Marshall holds a B.S. in Chemistry and an M.D. from the University of California, Los Angeles. She completed an internship in Internal Medicine at the University of Pennsylvania, Philadelphia and Internal Medicine residency at St Vincent Hospital in Portland, Oregon. Following a cardiology fellowship at the Oregon Health Sciences University, she served as an Assistant Professor at the University of Virginia School of Medicine in Charlottesville, an Associate Professor at the University of Los Angeles School of Medicine and held positions in private cardiology practices. Dr. Marshall has been an NIH and AHA grant recipient, was awarded a US Patent and has authored numerous scientific and clinical publications. She earned board certifications in Internal Medicine, Cardiovascular Diseases, Interventional Cardiology and Nuclear Cardiology.